[Antiarrhythmic therapy with β-receptor antagonists]

Area of Science:

• Cardiology
• Pharmacology

Background:

• Beta-blockers are a cornerstone in managing ischemic heart disease and cardiac dysfunction.
• Their mechanism involves modulating the sinus and atrioventricular nodes and myocardial refractory periods.

Purpose of the Study:

• To highlight the antifibrillatory effects of beta-blockers in reducing morbidity and mortality.
• To emphasize guideline recommendations for uptitrating beta-blocker dosage.
• To discuss the role of beta-blockers in atrial fibrillation management.

Main Methods:

• Review of current guidelines and therapeutic strategies for beta-blocker use.
• Discussion of the pharmacological effects of beta-blockers on cardiac electrophysiology.
• Consideration of future research directions for antiarrhythmic effects.

Main Results:

• Beta-blockers demonstrate complex antifibrillatory effects contributing to reduced mortality.
• Uptitration to the highest tolerated dose is recommended.
• In atrial fibrillation, beta-blockers are a preferred first-line or add-on therapy.

Conclusions:

• Beta-blockers are vital for reducing morbidity and mortality in cardiovascular diseases.
• Optimal management involves dose uptitration and consideration in atrial fibrillation.
• Further studies comparing selective beta-blockers and exploring IV formulations are warranted.